[144] Parker-Hannifin Corporation SEC Filing

Rhea-AI Filing Summary

Form 144 summary for Parker-Hannifin Corporation (PH). Proposed sale of 450 common shares with aggregate market value $330,000 on the NYSE.

Acquisition recorded as a stock award from the issuer on 04/24/2025, payment/award date same. Approximate sale date listed as 08/08/2025. Broker listed as Kestra, 5707 Southwest Pkwy bldg 2 STE 400, Austin TX 78735. Filing reports 128,410,000 shares outstanding and no securities sold in the past 3 months.

Filer represents they do not possess undisclosed material adverse information and acknowledges Rule 144 requirements.

Positive

• Transaction size is minimal: 450 shares versus 128,410,000 outstanding (immaterial to capital structure)
• No securities sold in prior 3 months: filing states "Nothing to Report" for recent sales

Negative

• None.

Insights

Securities Analyst

TL;DR Small, routine sale of recently awarded shares; immaterial to PH capital structure.

The filing notifies a proposed sale of 450 common shares valued at $330,000 on 08/08/2025. The shares were acquired as a stock award on 04/24/2025 and are to be sold through broker Kestra. Relative to the reported 128,410,000 shares outstanding, the lot represents approximately 0.00035% of outstanding common stock, making the transaction immaterial to market supply or EPS dilution. No prior sales in the past three months are reported, and the filer affirms no undisclosed material adverse information.

Corporate Governance Expert

TL;DR Insider monetization of compensation via Rule 144; procedure appears routine with no governance red flags.

The notice documents disposition of shares acquired as compensation under a stock award, sold pursuant to Rule 144 through an intermediary. The filing includes the standard representation regarding material information. The small size of the proposed sale and absence of recent sales by the filer reduce governance concerns; monitoring for any subsequent larger insider dispositions is recommended but not indicated here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Kestra 5707 Southwest Pkwy bldg 2 STE 400 Austin TX 78735	450	330000.00	128410000	08/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/24/2025	Stock Award	ISSUER			450	04/24/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PH Form 144 report?

The filing reports a proposed sale of 450 common shares of Parker-Hannifin (PH) with aggregate market value $330,000 on the NYSE.

When were the shares acquired and by what method for PH?

The shares were acquired on 04/24/2025 as a stock award from the issuer; payment/award date is listed as 04/24/2025.

What is the approximate sale date and broker for the PH sale?

Approximate sale date is 08/08/2025 and the broker listed is Kestra, 5707 Southwest Pkwy bldg 2 STE 400, Austin TX 78735.

How many PH shares are outstanding according to the filing?

The filing states 128,410,000 shares outstanding.

Has the filer sold any PH securities in the past three months?

No. The section "Securities Sold During The Past 3 Months" states Nothing to Report.

Does the filer assert any undisclosed material information in the PH Form 144?

By signing, the filer represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.